Stereotaxis (NYSE:STXS) announced that it entered into a securities purchase agreement to issue common stock for net proceeds of approximately $15 million. St. Louis, Mo.-based Stereotaxis said in a news release that the agreement with certain funds managed by Consonance Capital Management will see it issue approximately 3.66 million shares of common stock at $4.10 per […]
Bardy Diagnostics lands CE Mark for cardiac monitor patch
Bardy Diagnostics this week said it received CE mark certification for its 14-day version of the Carnation Ambulatory Monitor patch. The patch is a P=wave centric ambulatory cardiac patch monitor and arrhythmia detection device. It gives clinicians more flexibility to monitor patients over a longer period of time while expanding the portfolio of the company’s […]
TransMedics proposes public offering following positive OCS Liver Protect trial results
TransMedics (NSDQ:TMDX) today announced a public offering following positive results from a clinical trial for its organ care system. The Andover, Mass.-based organ transplant transportation technology developer revealed in a news release that it is offering $60 million in shares of common stock, plus a 30-day option to purchase additional shares that total up to 15% […]
15 heart devices that could boost their manufacturers’ sales
Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals […]
Windtree Therapeutics prices $20m offering
Windtree Therapeutics (OTCQB:WINT) announced today that it priced a public offering of common stock worth approximately $20 million. The Warrington, Pa.-based company’s offering includes more than 2.7 million units of common stock at $7.25 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock […]
Medtronic appoints new VP & CMO for coronary, renal denervation & structural heart
Medtronic (NYSE:MDT) announced that it appointed Dr. Jeffrey Popma as its new VP and chief medical officer for coronary, renal denervation and structural heart business. Popma, a professor of medicine at Harvard Medical School and director of interventional cardiology at Beth Israel Deaconess Medical Center in Boston, is slated to provide medical leadership across those businesses, […]
Alleviant Medical completes $6.5m offering
Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering. The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering […]
Edwards lands CE Mark for Pascal transcatheter valve repair system to treat TR
Edwards Lifesciences (NYSE:EW) announced today that it received CE Mark approval for its Pascal transcatheter valve repair system for treating tricuspid regurgitation (TR). Pascal won its indication in Europe for the percutaneous reconstruction of the tricuspid valve through leaflet repair by tissue approximation. The device uses clasps and paddles to grasp the leaflets and facilitate coaptation, […]
Medtronic touts positive results for Melody TPV, Harmony TPV
Medtronic (NYSE:MDT) today announced the results of two successful clinical trials for its Melody transcatheter pulmonary valve (TPV) therapy. The Fridley, Minn.-based medtech giant virtually presented its 10-year outcomes at the 2020 Society for Cardiovascular Angiography & Interventions (SCAI) scientific sessions. Melody demonstrated strong long-term hemodynamic and safety outcomes, while the investigational Harmony TPV pivotal trial […]
How AI could help health providers diagnose COVID-19
When it comes to diagnosing treating COVID-19, timeliness is imperative to avoid patient deaths. Several companies are developing artificial intelligence-based algorithms to help doctors analyze and diagnose COVID-19 in patients quickly. The coronavirus has affected more than 3.7 million people globally, with the U.S. experiencing the most COVID-19 cases at just over 1.2 million so […]
Eko lands EUA for ECG-based algorithm for COVID-19 patients
Eko announced today that the FDA has issued the company an emergency use authorization (EUA) for its novel ECG-based algorithm designed to provide an easily accessible, rapid screening test for low ejection fraction (low EF), a weak heart pump. Awarded an FDA breakthrough device designation in December 2019, the algorithm’s regulatory review has been further […]
- 1
- 2
- 3
- …
- 281
- Next Page »
